Accelerate Diagnostics, Inc. (AXDXQ)
OTCMKTS · Delayed Price · Currency is USD
0.00
0.00 (0.00%)
Aug 12, 2025, 4:00 PM EDT
Elevation Oncology Market Cap
Accelerate Diagnostics has a market cap or net worth of $25.00 as of August 12, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
25.00
Enterprise Value
50.28M
Revenue
11.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
n/a
Market Cap Chart
Since December 15, 1995, Accelerate Diagnostics's market cap has decreased from 2.86M to 25.00, a decrease of -100.00%. That is a compound annual growth rate of -32.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 25.00 | -100.00% |
| Dec 31, 2024 | 30.05M | -47.31% |
| Dec 29, 2023 | 57.04M | -18.47% |
| Dec 30, 2022 | 69.96M | -80.76% |
| Dec 31, 2021 | 363.65M | -15.88% |
| Dec 31, 2020 | 432.29M | -53.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 366.75M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |